Federal Agricultural Mortgage Corp. Cl A (AGMA) Financials

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Federal Agricultural Mortgage Corp. Cl A (AGMA) Financials Nov 14, 2014, 2:57 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Federal Agricultural Mortgage Corp. Cl A


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 169.6M 227.1M 256.36M 266.82M 254.53M
Total Investment Income (40.14M) (36.94M) (44.8M) 325,000 4.55M
Sundry Revenue/Income 1.44M 1.24M 1.65M (23.14M) (11.56M)
Trading Account Income - - - - (819,000)
Trust Income, Commissions & Fees 31.81M 24.09M 24.82M 24.96M 26.96M
Commission & Fee Income 31.81M 24.09M 24.82M 24.96M 26.96M
Total Expense 18.42M 160.61M 182.65M 176.58M 124.72M
Total Interest Expense 90.59M 142.67M 153.38M 142.69M 137.28M
Depreciation & Amortization Expense - - 0 - 0
Other Operating Expense (99.87M) (9.75M) 1.04M 18.61M (26.94M)
2009 2010 2011 2012 2013 5-year trend
Operating Income 151.18M 66.5M 73.71M 90.24M 129.81M
Non-Operating Income (Expense) 4.93M 0 (29.06M) 878,000 0
Non-Operating Interest Income 0 0 0 0 0
Miscellaneous Non Operating Expense 4.93M 0 (29.06M) 878,000 0
Equity in Affiliates (Pretax) 0 0 0 - -
Unusual Expense 3.99M 0 0 0 (1.46M)
Pretax Income 152.12M 66.5M 44.65M 91.12M 131.27M
Income Taxes 52.52M 13.8M 5.8M 22.16M 33.75M
Income Tax - Current - Domestic 16.9M 14.32M 24.74M 24.14M 27.08M
Income Tax - Current - Foreign 0 0 0 - -
Income Tax - Deferred - Domestic 35.62M (524,000) (18.94M) (1.98M) 6.67M
Income Tax - Deferred - Foreign 0 0 0 - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 (5.78M) 0 0 0
Consolidated Net Income 99.6M 46.92M 38.85M 68.96M 97.52M
Minority Interest Expense 0 20.71M 22.19M 22.19M 22.19M
Net Income 99.6M 26.21M 16.66M 46.77M 75.33M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 99.6M 26.21M 16.66M 46.77M 75.33M
Preferred Dividends 17.3M 4.13M 2.88M 2.88M 3.5M
Net Income Available to Common 82.3M 22.08M 13.78M 43.89M 71.83M
EPS (Basic) 8.12 2.16 1.33 4.19 6.64
Basic Shares Outstanding 10.14M 10.23M 10.34M 10.48M 10.82M
EPS (Diluted) 8.04 2.08 1.28 3.98 6.41
Diluted Shares Outstanding 10.23M 10.62M 10.8M 11.02M 11.21M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing K-12 Education: Five Star's Virtual Help Desk

Updated Category News Views 159

Five Star Technology Solutions' Anniversary Celebration Five Star Technology Solutions proudly commemorates three years since the launch of its innovative Virtual Help Desk (vHD), a service dedicated to enhancing K–12 education. This powerful tool has redefined how schools and districts obtain technical support, resulting in increased efficiency and cost savings, while...

Continue Reading
Exploring the Dynamics of Small-Cap Investments in RVT

Updated Category News Views 181

Understanding Royce Small-Cap Trust Royce Small-Cap Trust (NYSE: RVT) stands as the oldest and largest closed-end fund dedicated to small-cap stocks. By focusing on these smaller companies, the trust has carved out a unique niche in the investment landscape. Key Highlights The fund enjoys an impressive weekly trading volume of around 974,286 shares, reflecting strong...

Continue Reading
Projected Growth of Peripheral Intravenous Catheters Market

Updated Category News Views 215

Overview of the Peripheral Intravenous Catheters Market The peripheral intravenous catheters (PIVCs) market is on track to reach a striking valuation of USD 10.9 billion by 2032. This expected growth is primarily propelled by the rising number of both elective and emergency surgeries conducted around the world. Increasing Need for Intravenous Access Every year, over 310...

Continue Reading
Vaxart Announces New Lead Independent Director Appointment

Updated Category News Views 122

Appointment of W. Mark Watson SOUTH SAN FRANCISCO, Calif. — Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company, proudly announces the appointment of W. Mark Watson as its Lead Independent Director. With a wealth of knowledge spanning over 50 years in the field of accounting and business, Mr. Watson is set to significantly enhance the strategic direction...

Continue Reading
Legal Review of Potential Securities Fraud by Stellantis N.V.

Updated Category News Views 176

Understanding the Investigation into Stellantis N.V. There is an ongoing investigation regarding potential securities fraud claims against Stellantis N.V. (NYSE: STLA). This inquiry arises due to allegations that the company may have made inaccurate statements about its business performance and future prospects. The focus of the investigation highlights key elements of...

Continue Reading